Marathon Nextgen Realty wins BSE-NSE scheme nods 2026

Exchange observation letters clear a key procedural step

Marathon Nextgen Realty Limited said it has received observation letters carrying a “no adverse objection” from both BSE Limited and the National Stock Exchange of India Limited (NSE) for its Composite Scheme of Amalgamation and Arrangement. The BSE observation letter is dated March 25, 2026, and the company disclosure around the BSE receipt was made on March 26, 2026. The company later announced on March 31, 2026 that it received a similar observation letter from NSE dated March 30, 2026. With these letters in place, the company can proceed toward filing the scheme with the National Company Law Tribunal (NCLT), subject to the next set of approvals. The scheme remains contingent on shareholder and creditor approvals and further statutory and regulatory clearances, including NCLT approval.

What the composite scheme covers

The company described the proposal as a comprehensive corporate restructuring under a composite scheme. As outlined in the disclosure, the scheme involves seven companies through amalgamation and demerger transactions. It is also subject to 16 SEBI compliance requirements, indicating a multi-step process with documentation and procedural checks. While exchange observation letters are a significant milestone, they do not constitute final approval of the scheme. The company has highlighted that several critical approvals are still pending before the restructuring can be completed.

BSE letter validity sets the NCLT submission window

Marathon Nextgen Realty stated that the BSE observation letter is valid for six months from March 25, 2026, specifically for submission to NCLT. This window is an important practical constraint for the next stage of filings and approvals. In the company’s communication, the observation letter is positioned as a prerequisite step for proceeding with the merger and arrangement plan. The scheme still needs to pass through shareholder and creditor approvals across the involved entities. Any additional statutory or regulatory approvals, if required as the process advances, would also need to be addressed before final sanction.

NSE observation letter follows within five days

After the BSE communication, the company said it received NSE’s “no adverse objection” within five days, dated March 30, 2026. The NSE reference number was disclosed as NSE/LIST/48217, with a validity period of six months. Together, the two exchange letters provide the company the procedural clearance to move toward NCLT filing under the prescribed regulatory framework. The company indicated that the immediate next step is NCLT filing and approval.

Key milestones at a glance

Appointed date and board approval noted in the disclosure

In the merger and arrangement plan discussed in the disclosure, the company stated that the Marathon Group’s Board of Directors had approved the proposed plan with an Appointed Date of January 01, 2025. Appointed dates are commonly used in schemes to define the effective economic date for transactions, subject to later approvals. The company also flagged that investors should monitor shareholder and creditor approvals, track the timeline for NCLT submission within the six-month window, and watch for any further statutory or regulatory clearances.

Investor engagement calendar: meetings and results schedule

Alongside the regulatory updates, Marathon Nextgen Realty outlined multiple investor engagement events. The company announced it would host a group meeting for institutional investors and analysts on June 30, 2026, in Mumbai from 11:00 AM to 12:00 Noon. It said the meeting aims to discuss business operations and financial performance, and the disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also noted that the schedule is subject to change due to exigencies on the part of participants or the company.

The company separately stated it would conduct a physical group meeting with institutional investors and analysts on August 14, 2025. It also disclosed that it would announce Q2 and H1 FY26 results on November 11, 2025, followed by an investor conference call on November 13, 2025. Details shared for the conference call included India dial-in numbers (+91 22 6280 1107 / +91 22 7115 8008) and international toll-free numbers for the USA, UK, Singapore, and Hong Kong, along with a DiamondPassTM pre-registration facility for quicker entry.

Background: NCLT process and earlier scheme references

The material also includes references to an NCLT-led process for a scheme of amalgamation involving Marathon Nextgen Townships Private Limited (MNTPL), described as a wholly owned subsidiary, with Marathon Nextgen Realty Limited. In that matter, board approvals were referenced as having taken place on November 7, 2019 and November 14, 2019, with an appointed date fixed as April 1, 2019. The NCLT-directed equity shareholder meetings were stated to be scheduled for March 23, 2020 at the Indian Merchant Chambers, Churchgate, Mumbai, with postal ballot and e-voting running from February 22, 2020 (9:00 a.m.) to March 22, 2020 (5:00 p.m.). The documents also mention an order delivered on 14.07.2023.

These references underline that schemes typically involve multiple stages: directions for meetings, notices, voting windows, creditor intimation, and ultimately tribunal sanction. For investors, the current composite restructuring will similarly need to clear procedural steps beyond exchange observation letters.

Market snapshots disclosed alongside the updates

Price points appeared alongside the disclosed information, including ₹417.80 with a move of -2.75 (-0.65%) and another snapshot showing MARATHON at ₹488.35 up 8.70 (1.81%). The material also carried a market-cap figure of ₹4,158 crore and a “current price” of ₹616. These figures were presented as snapshots in the source information and reflect market levels at the respective timestamps shown.

Why the exchange letters matter for shareholders

Exchange observation letters are important because they indicate the stock exchanges have reviewed the scheme documentation within the applicable framework and issued “no adverse objection,” subject to stated conditions. But the scheme still hinges on approvals from shareholders, creditors, and authorities such as NCLT. The six-month validity period adds a defined timeline for the company to move the filing process forward. Investors tracking the restructuring will typically focus on the progress of filings, meeting notices, voting outcomes, and whether any additional regulatory approvals are sought as the process advances.

Conclusion

Marathon Nextgen Realty’s receipt of “no adverse objection” observation letters from BSE (March 25, 2026) and NSE (March 30, 2026) moves its composite restructuring scheme to the next procedural stage, with NCLT filing identified as the next step. Separately, the company has laid out an investor engagement calendar including a Mumbai group meeting on June 30, 2026, and FY26 interim results and a follow-up call in November 2025. The next key milestones to watch, based on the disclosures, are shareholder and creditor approvals and submission of the scheme to NCLT within the validity period of the observation letters.